Dicyclomine Market Poised for Steady Growth on Rising IBS Burden and Generic Availability
The global dicyclomine market is set to grow steadily over the next decade, supported by a persistent prevalence of irritable bowel syndrome (IBS), expanding access to generics, and incremental formulation advances that improve adherence, according to multiple industry analyses. Market assessments indicate global revenues in the broad dicyclomine category ranging from approximately USD 500 million in 2024 with a projected trajectory toward USD 750 million by 2033 at about 5% CAGR, with some estimates placing the 2024–2031 outlook higher due to broader product scope and regional uptake variations. Market Snapshot Market size and growth: Recent studies estimate the dicyclomine market at around USD 500 million in 2024, with projections to reach roughly USD 750 million by 2033, reflecting an approximate CAGR of 5% over the medium term. Another analysis models the broader market at USD 1.5 billion in 2024 with a projected USD 2.7 billion by 2031 at a CA...